Toxoplasma gondii in Cats: Zoonotic Risks and Environmental Contamination

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan protozoan parasite capable of infecting virtually all warm-blooded vertebrates [1, 2]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing form), bradyzoites (slowly dividing form within tissue cysts), and sporozoites (within sporulated oocysts) [2, 3]. Felids, including domestic cats (Felis catus), serve as the definitive hosts in which the sexual phase of the life cycle occurs [2, 3]. The enteroepithelial cycle begins when a cat ingests tissue cysts containing bradyzoites from an intermediate host (e.g., rodents, birds) or, less efficiently, oocysts from the environment [3, 28]. Following ingestion, bradyzoites invade the epithelial cells of the small intestine and undergo multiple rounds of asexual multiplication (schizogony) followed by gametogony, culminating in the formation of unsporulated oocysts [2, 3]. These oocysts are shed in the feces, typically beginning 3 to 10 days post-infection and continuing for 1 to 3 weeks [2, 3]. A single cat can excrete millions of oocysts during this patent period [2, 3]. Once shed, oocysts sporulate in the environment within 1 to 5 days under favorable conditions of temperature and humidity, becoming infective to intermediate hosts, including humans [2, 4]. Sporulated oocysts are remarkably resilient, surviving for months to years in soil, water, and on surfaces [4, 30].

Epidemiology and Global Seroprevalence

Toxoplasma gondii infection in cats is distributed worldwide, with seroprevalence rates varying considerably by geographic region, cat lifestyle (stray versus owned), age, and diagnostic methodology [5, 6, 7]. A meta-analysis of studies from mainland China reported a pooled seroprevalence of 24.5% (95% CI: 20.1-29.0) in cats between 1995 and 2016, with stray cats showing significantly higher odds of seropositivity compared to pet cats (OR = 3.00, 95% CI: 1.60-5.64) [6]. A subsequent meta-analysis covering 2016-2020 estimated a seroprevalence of 19.9% (95% CI: 15.9-23.9) in Chinese cats, suggesting a possible decline [5]. In a large survey across 10 regions of China, antibodies were detected in 4.2% of urban pet cats (62/1478) and 20.9% of stray cats (9/43), with age and lifestyle identified as significant risk factors [7]. In Kunming, Southwest China, a seroprevalence of 72.7% (168/231) was reported in urban cats, one of the highest recorded rates globally [35].

In South America, seroprevalence data are highly variable. In Brazil, a study in Rio de Janeiro found anti-T. gondii antibodies in 8.1% (22/272) of domiciled cats using an indirect fluorescent antibody test (IFAT) [31]. In the Brazilian semiarid region, a seroprevalence of 53.4% (55/103) was observed in owned cats, with a high rate of coinfection with feline immunodeficiency virus (FIV) [32]. In Lima, Peru, a seroprevalence of 11% (17/154) was reported using indirect hemagglutination [8]. In Colombia, seroprevalence in cats has been documented, with genetic characterization of isolates revealing diverse genotypes [9].

In Europe, a study in Cyprus reported a seroprevalence of 32.3% (50/155) in cats, with FIV seropositivity and lack of vaccination history identified as risk factors [10]. In Germany, serotyping of T. gondii in cats revealed a predominance of type II infections [11]. In Sweden, antibodies were detected in cats, dogs, and horses, with cats showing a higher prevalence than the other species [12]. In Slovakia, a coprological survey of 2261 cats found T. gondii oocysts in only 0.4% of animals, with shelter cats showing a higher overall prevalence of intestinal parasites (40.3%) compared to owned cats (29.5%) [33].

In the Middle East, a study in Iran reported T. gondii antibodies in cats, goats, and sheep, with cats serving as a key sentinel for environmental contamination [13]. In Mashhad, Iran, T. gondii DNA was detected in 4% (7/175) of fecal samples from stray cats, and a type II genotype was isolated from a brain sample [34]. In Turkey, seroprevalence in cats from the Kars region has been documented [14]. In Sri Lanka, a seroprevalence of 26.5% was reported in cats from Colombo [15]. In Thailand, a seroprevalence of 18.7% (60/321) was found in outdoor cats in Bangkok, with increasing age identified as a risk factor [16].

In Africa, a study in Pakistan (South Punjab) detected T. gondii DNA in 3.5% (7/200) of cat fecal samples by PCR, with phylogenetic analysis showing close relation to an atypical strain (AF249696) [1]. In the same study, seroprevalence in humans living in the same vicinity was 26% (52/200) in Khanewal and 24.5% (49/200) in Sahiwal [1].

Zoonotic Risks and Environmental Contamination

Cats are the primary source of environmental contamination with T. gondii oocysts, which are the main route of infection for intermediate hosts, including humans [1, 17, 30]. Oocysts are shed in the feces of infected cats and, after sporulation, can remain infective in soil, water, and on vegetation for extended periods [4, 30]. The risk of human infection is directly correlated with the density of free-roaming and stray cat populations, as well as with cat defecation habits in peridomestic environments [17, 6, 16]. Studies have shown that cat ownership is a risk factor for human seropositivity, with cat owners showing higher seroprevalence rates than non-owners [17]. In a study in Saudi Arabia, 30% of cat-owning women were seropositive for T. gondii compared to 17.5% of non-owners [17].

Environmental contamination is influenced by local meteorological conditions, with temperature and humidity affecting oocyst survival and sporulation rates [4]. Oocysts can be transported via water runoff, wind, and mechanical vectors such as flies and earthworms, leading to widespread distribution in the environment [4, 30]. The presence of oocysts in soil and water poses a risk to humans through ingestion of contaminated produce, water, or through direct contact with contaminated soil (e.g., gardening) [1, 30]. In Brazil, the high seroprevalence in cats and humans underscores the importance of environmental contamination as a public health concern [31, 32]. The spatial distribution of seropositive cats in Rio de Janeiro showed clustering in the west and north zones, correlating with areas of lower socioeconomic status and higher stray cat density [31].

Clinical Signs and Pathology in Cats

Most T. gondii infections in cats are subclinical [3, 30]. Clinical disease, termed feline toxoplasmosis, is most commonly observed in immunocompromised cats, including those coinfected with FIV or feline leukemia virus (FeLV), and in very young kittens [32]. The most frequently reported clinical signs are referable to the respiratory, gastrointestinal, and nervous systems. Respiratory signs include dyspnea, tachypnea, and cough due to interstitial pneumonia [3]. Gastrointestinal signs include anorexia, vomiting, diarrhea, and abdominal pain, often associated with enteritis and mesenteric lymphadenopathy [3]. Neurological signs, which can be severe, include ataxia, seizures, tremors, circling, and behavioral changes, resulting from meningoencephalitis and focal necrotizing lesions in the brain and spinal cord [3]. Ocular signs, such as uveitis, chorioretinitis, and optic neuritis, are also common [3]. Hepatic involvement can lead to icterus and elevated liver enzymes [3]. Pathological findings at necropsy include multifocal necrotic foci in the liver, lungs, pancreas, and brain, with associated inflammation [3]. Tissue cysts containing bradyzoites are often found in the brain, skeletal muscle, and myocardium [3].

Diagnostics

Diagnosis of T. gondii infection in cats can be achieved through serological, molecular, and coprological methods.

Serological Methods

Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common diagnostic approach [18, 19, 30]. Several serological platforms are available, including enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody test (IFAT), modified agglutination test (MAT), and immunochromatographic tests (ICTs) [18, 20, 19, 16, 30]. The choice of antigen is critical for test performance. Recombinant antigens such as GRA7, SAG2, and GRA6 have been evaluated for serodiagnosis in cats [18, 19]. GRA7 has demonstrated higher sensitivity compared to SAG2 and GRA6 in ELISA [19]. An ICT based on the GRA7 antigen has been shown to be a reliable point-of-care test for detecting anti-T. gondii antibodies in cats, with performance comparable to conventional ELISA [18]. Similarly, an ICT using recombinant SAG2 has been developed for rapid serodiagnosis [20]. Western blotting is another serological method used for confirmation, particularly in research settings [30]. In a study in Mexico, Western blot and ELISA were used to determine a seroprevalence of 14.8% (44/297) in cats [30].

Molecular Methods

Polymerase chain reaction (PCR) targeting the B1 gene or the 529 bp repetitive element is widely used for direct detection of T. gondii DNA in blood, feces, and tissues [1, 21, 22, 29, 30, 34]. PCR is more sensitive than coprological examination for detecting oocyst shedding [21, 34]. Real-time PCR (qPCR) allows for quantification of parasite burden [22]. Isothermal amplification methods, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), have been developed for field-deployable diagnostics [22, 29]. A LAMP-lateral flow dipstick (LAMP-LFD) assay targeting the 529 bp element achieved a detection limit of 1 fg of T. gondii DNA and showed no cross-reactivity with other parasites [29]. An RPA-CRISPR/Cas12a assay combined with a lateral flow band (LFA) and a digital visualization instrument was able to detect the B1 gene with a limit of 31 copies/μL within 55 minutes [22]. This assay was used to survey stray cats and dogs in Zhejiang, China, finding positive rates of 8.0% and 4.0%, respectively [22].

Coprological Methods

Microscopic examination of feces using flotation techniques can detect T. gondii oocysts, but this method has low sensitivity due to intermittent shedding and the morphological similarity of oocysts to those of other coccidians, such as Hammondia hammondi and Besnoitia spp. [2, 33, 34]. PCR confirmation is recommended for positive samples [34]. In a study in Iran, Toxoplasma-like oocysts were observed in 2.2% (4/175) of fecal samples, but only one was confirmed by PCR [34]. In Slovakia, T. gondii oocysts were confirmed by PCR in 0.4% of 2261 feline fecal samples [33].

Diagnostic Decision Tree

graph TD
    A[Clinical suspicion of toxoplasmosis in cat], > B{Serological testing};
    B, > C[Positive IgG/IgM];
    B, > D[Negative];
    C, > E{Acute or chronic infection?};
    E, > F[High IgM, low IgG: acute];
    E, > G[High IgG, low IgM: chronic/latent];
    F, > H[Consider molecular testing (PCR on blood/fecal)];
    G, > I[No further action usually needed];
    H, > J[PCR positive: active infection/shedding];
    H, > K[PCR negative: no active shedding];
    D, > L[Consider retesting in 2-4 weeks if high suspicion];
    L, > M[Seroconversion?];
    M, > N[Yes: recent infection];
    M, > O[No: no infection];
    J, > P[Implement hygiene and control measures];
    K, > Q[Monitor clinically];

Treatment

Treatment of clinical toxoplasmosis in cats is aimed at reducing the tachyzoite burden. The standard therapeutic regimen consists of clindamycin hydrochloride administered orally or intramuscularly at a dose of 10-12 mg/kg every 12 hours for 2-4 weeks [3]. Alternative therapies include trimethoprim-sulfonamide combinations (e.g., trimethoprim-sulfadiazine at 15 mg/kg every 12 hours) [3]. Pyrimethamine combined with a sulfonamide can also be used but is associated with a higher risk of adverse effects, including bone marrow suppression and anorexia [3]. Treatment is most effective when initiated early in the course of clinical disease. Supportive care, including fluid therapy, nutritional support, and anticonvulsants for neurological signs, is often necessary [3]. It is important to note that treatment does not eliminate tissue cysts, and cats may remain seropositive for life [3].

Control and Prevention

Control of T. gondii infection in cats and reduction of environmental contamination require a multifaceted approach.

Management of Cats

1. Prevent predation: Keeping cats indoors reduces their exposure to infected intermediate hosts (rodents, birds) [6, 7].
2. Dietary management: Feeding only commercially processed or thoroughly cooked food prevents ingestion of tissue cysts [8, 31]. Raw meat diets are a significant risk factor for infection [8, 31].
3. Litter box hygiene: Daily removal of feces prevents oocyst sporulation, as freshly shed oocysts are not immediately infective [2]. Litter boxes should be cleaned with hot water (above 70 degrees Celsius) to inactivate oocysts [2].
4. Stray cat population control: Trap-neuter-return (TNR) programs and responsible pet ownership can reduce the population of free-roaming cats, thereby decreasing environmental oocyst contamination [6, 7].

Environmental Management

1. Soil and water protection: Cover sandboxes and garden areas to prevent cat defecation. Avoid using untreated water from sources potentially contaminated with cat feces [4, 30].
2. Produce hygiene: Thoroughly wash fruits and vegetables before consumption to remove any adherent oocysts [1].
3. Hand hygiene: Wash hands thoroughly after handling cat litter, gardening, or contact with soil [17].

Public Health Education

Educational campaigns should target high-risk groups, including pregnant women and immunocompromised individuals, emphasizing the importance of cat litter hygiene and avoiding contact with stray cats [17, 10]. The availability of educational resources, such as a toxoplasmosis cat video, can aid in disseminating information about transmission risks and prevention measures. In regions with high seroprevalence, such as parts of Brazil, targeted public health interventions are particularly important [31, 32]. The term toxoplasmosis cats brazil is frequently searched, reflecting the high disease burden and public awareness in that country.

References

[1] M. Abdul Hafeez, Muntazir Mehdi, Faiza Aslam et al. Molecular Characterization of Toxoplasma gondii in Cats and Its Zoonotic Potential for Public Health Significance. Pathogens, 2022. URL: https://www.semanticscholar.org/paper/c4529a944bd44d697f46627da783fc60c9ed8201

[2] J. K. Frenkel, J. P. Dubey, N. Miller. Toxoplasma gondii in Cats: Fecal Stages Identified as Coccidian Oocysts. Science, 1970. URL: https://www.semanticscholar.org/paper/d71bf42a7bfe263c7f5b2d06f5015fba6fd984e6

[3] J. Dubey. TACHYZOITE-INDUCED LIFE CYCLE OF TOXOPLASMA GONDII IN CATS. Journal of Parasitology, 2002. URL: https://www.semanticscholar.org/paper/b76230f3d5bdaad900e88dfdf5d1bbc3517ed337

[4] Eve Afonso, Philippe Thulliez, Emmanuelle Gilot-Fromont. Local meteorological conditions, dynamics of seroconversion to Toxoplasma gondii in cats (Felis catus) and oocyst burden in a rural environment. Epidemiology and Infection, 2009. URL: https://www.semanticscholar.org/paper/c946e6fe1c5f433e69e53bc687818beac8008dea

[5] Siyu Zhou, Ziyin Sang, Lijun Wang et al. Seroprevalence of Toxoplasma gondii in cats in mainland China 2016–2020: a meta-analysis. Journal of Veterinary Sciences, 2021. URL: https://www.semanticscholar.org/paper/e4b990f84422d4e235403196e2d7adc858fba5e3

[6] Huan Ding, Yu-meng Gao, Yao Deng et al. A systematic review and meta-analysis of the seroprevalence of Toxoplasma gondii in cats in mainland China. Parasites & Vectors, 2017. URL: https://www.semanticscholar.org/paper/707867d46141d54e461786e27b0d911be73ea024

[7] N. Xia, Nuo Ji, Longjiao Li et al. Seroprevalence and risk factors of Toxoplasma gondii in urban cats from China. BMC Veterinary Research, 2022. URL: https://www.semanticscholar.org/paper/fb405e46df8126da1c8172fe0343cfeff8606f6b

[8] L. Cerro, A. Rubio, R. Pinedo et al. Seroprevalence of Toxoplasma gondii in cats (Felis catus, Linnaeus 1758) living in Lima, Peru. Revista Brasileira de Parasitologia Veterinaria, 2014. URL: https://www.semanticscholar.org/paper/6ab7c74cee33cc4d6a2b6830850a46eff1469b1a

[9] J. Dubey, C. Su, J. A. Côrtes et al. Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Veterinary Parasitology, 2006. URL: https://www.semanticscholar.org/paper/bf3bad1e425590a8f81e93aa8b63bc0d91821

[10] C. Attipa, Christos Yiapanis, S. Tasker et al. Seroprevalence of Toxoplasma gondii in Cats from Cyprus. Pathogens, 2021. URL: https://www.semanticscholar.org/paper/2428e1e6e21a05707a16e1cdd3827c4b58f3cc9e

[11] P. Maksimov, J. Zerweck, J. Dubey et al. Serotyping of Toxoplasma gondii in Cats (Felis domesticus) Reveals Predominance of Type II Infections in Germany. PLoS ONE, 2013. URL: https://www.semanticscholar.org/paper/908aa794b2b085adb57f5fe7a46fb23ce4675d93

[12] A. Uggla, S. Mattson, N. Juntti. Prevalence of Antibodies to Toxoplasma gondii in Cats, Dogs and Horses in Sweden. Acta Veterinaria Scandinavica, 1989. URL: https://www.semanticscholar.org/paper/5bdc32a98b6dbce8649dbee60d641bf94a7a5751

[13] M. Derakhshan, M. Mousavi. Serological survey of antibodies to Toxoplasma gondii in cats, goats, and sheep in Kerman, Iran. Comparative Clinical Pathology, 2014. URL: https://www.semanticscholar.org/paper/00b3eb21bab9b98ab73447bbd18f6a98821f906f

[14] Erkılıç, C. Babür, A. H. Kırmızıgül et al. Seroprevalence of Toxoplasma gondii in Cats The Seroprevalence of Toxoplasma gondii in Cats from the Kars Region, Turkey. Journal, 2016. URL: https://www.semanticscholar.org/paper/9d84851c1dad35e25b3c31ab8ac9678dab68fdf4

[15] V. A. Kulasena, R. Rajapakse, R. Rajapakse et al. Seroprevalence of Toxoplasma gondii in Cats from Colombo, Sri Lanka. Journal of Parasitology, 2011. URL: https://www.semanticscholar.org/paper/e8cc2045b3cff1638c890ee26b1563258a0995b

[16] A. Huertas-López, Woraporn Sukhumavasi, G. Álvarez-García et al. Seroprevalence of Toxoplasma gondii in outdoor dogs and cats in Bangkok, Thailand. Parasitology, 2021. URL: https://www.semanticscholar.org/paper/a198bcb77

[17] F. A. Khayat. Detection of Toxoplasma Gondii in Cats and Seroprevalence in Women. Indian Journal of Veterinary Sciences & Biotechnology, 2022. URL: https://www.semanticscholar.org/paper/6d65e09ff28416c75071dbd6bacf674eca5a0068

[18] R. H. Ybañez, H. Kyan, Y. Nishikawa. Detection of antibodies against Toxoplasma gondii in cats using an immunochromatographic test based on GRA7 antigen. Journal of Veterinary Medical Science, 2020. URL: https://www.semanticscholar.org/paper/b728e27491bbb5242419882d21380d8ab4b80073

[19] Serges Sabukunze, Haorong Gu, Lin Zhao et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science, 2024. URL: https://www.semanticscholar.org/paper/9f5d168c43119aed8d92f0b3115eb05d8db3dc99

[20] Xiaohong Huang, X. Xuan, H. Hirata et al. Rapid Immunochromatographic Test Using Recombinant SAG2 for Detection of Antibodies against Toxoplasma gondii in Cats. Journal of Clinical Microbiology, 2004. URL: https://www.semanticscholar.org/paper/c18123c47f31d49dcc4ddd78138ee55c8d51245d

[21] A. Montoya, G. Miró, M. Mateo et al. Detection of Toxoplasma gondii in cats by comparing bioassay in mice and polymerase chain reaction (PCR). Veterinary Parasitology, 2009. URL: https://www.semanticscholar.org/paper/462fa6f827257b21d0bce2f40f797b95e3946f41

[22] Hao Sun, Jiyuan Fan, Hongkun Chu et al. RPA-CRISPR/Cas12a-LFA combined with a digital visualization instrument to detect Toxoplasma gondii in stray dogs and cats in Zhejiang province, China. Microbiology Spectrum, 2024. URL: https://www.semanticscholar.org/paper/f6dffc0f62f24e2b88a7d9c25876eb0ea43eefc6

[23] Erratum: Toxoplasma gondii in Cats: Fecal Stages Identified as Coccidian Oocysts. Science, 1970. URL: https://www.semanticscholar.org/paper/2107bb5121cb5c58225021fd2dde7a58672848b7

[24] Monica L DeFeo, J. Dubey, T. Mather et al. Epidemiologic investigation of seroprevalence of antibodies to Toxoplasma gondii in cats and rodents. American Journal of Veterinary Research, 2002. URL: https://www.semanticscholar.org/paper/0a6573de3d60fd1cac4140b9d976a24b3dd7d2b6

[25] Vasha Hsu, D. Grant, A. Zajac et al. Prevalence of IgG antibodies to Encephalitozoon cuniculi and Toxoplasma gondii in cats with and without chronic kidney disease from Virginia. Veterinary Parasitology, 2011. URL: https://www.semanticscholar.org/paper/217fb90da1912d5c3d3d83f33ef4a37fe5373506

[26] V. Svobodová, Z. Knotek, M. Svoboda. Prevalence of IgG and IgM antibodies specific to Toxoplasma gondii in cats. Veterinary Parasitology, 1998. URL: https://www.semanticscholar.org/paper/2c5ac51e2eb152df4b153df8a429b64088b45fee

[27] Alexander D. Bennett, D. Gunn-Moore, M. Brewer et al. Prevalence of Bartonella species, haemoplasmas and Toxoplasma gondii in cats in Scotland. Journal of Feline Medicine and Surgery, 2011. URL: https://www.semanticscholar.org/paper/998008087d5e2c01bf95fa88f10d1534ea2a53a5